Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Mar 10;13(9):1625–1632.e1. doi: 10.1016/j.cgh.2015.02.044

Figure 2.

Figure 2

Weight loss in the genotype guided therapy (GT) and the standard therapy (ST) groups. (A) Percentage of participants who achieved at least 5% weight loss. (B) Percentage weight lost by participants at 8 and 24 weeks. Adherence is a predictor of weight loss by both the genotype guided therapy (GT) and the standard therapy (ST) groups.